β₁-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia

Keyphrases

• Adaptation to Hypoxia 10%
• Adrenergic Activation 10%
• Adrenergic Activity 10%
• Adrenergic Receptors 100%
• Adrenoceptor Antagonist 10%
• Area at Risk 60%
• Cardioprotection 100%
• Collateral Blood Flow 10%
• Day Programs 10%
• De Novo Protein Synthesis 10%
• Fibrillation 10%
• FiO2 10%
• Hematocrit 10%
• Hypoxia 10%
• Infarct Size 60%
• Intermittent Hypoxia 100%
• Ischemia 10%
• Ischemic Injury 10%
• Ischemic Myocardium 10%
• Left Anterior Descending Coronary Artery 10%
• Metoprolol 40%
• Myocardial Ischemia 10%
• Myocardial Ischemic Injury 10%
• Myocardium 10%
• Normobaric Hypoxia 10%
• Normoxic 10%
• Progressive Development 10%
• Receptor Antagonism 100%
• Reperfusion 10%
• Sham 30%
• Ventricular Fibrillation 10%
• Ventricular Tachycardia 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Adrenergic Receptor 100%
• Heart Infarction 10%
• Heart Muscle Ischemia 20%
• Heart Ventricle Fibrillation 10%
• Heart Ventricle Tachycardia 20%
• Hypoxia 30%
• Infarction 50%
• Injury 20%
• Intermittent Hypoxia 100%
• Ischemia 10%
• Metoprolol 40%

Veterinary Science and Veterinary Medicine

• Collateral Circulation 20%
• Dog 100%
• Ischemia 40%
• Metoprolol 80%
• Myocardial Infarction 20%
• Ventricular Fibrillation 20%
• Ventricular Tachycardia 40%